# Increasing DR Screening Through TOP: Supporting Implementation and Identifying Opportunities for Scale up in Ontario

> **NCT03927859** · NA · UNKNOWN · sponsor: **Women's College Hospital** · enrollment: 420 (estimated)

## Conditions studied

- Diabetes Mellitus, Type 2
- Diabetes Mellitus, Type 1

## Interventions

- **OTHER:** a mail letter, a phone call and a phone call plus mailed letter

## Key facts

- **NCT ID:** NCT03927859
- **Lead sponsor:** Women's College Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2018-07-05
- **Primary completion:** 2019-06-30
- **Final completion:** 2019-08-30
- **Target enrollment:** 420 (ESTIMATED)
- **Last updated:** 2019-04-25

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03927859

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03927859, "Increasing DR Screening Through TOP: Supporting Implementation and Identifying Opportunities for Scale up in Ontario". Retrieved via MORVS 2026-10-16 from https://api.morvs.ai/clinical/NCT03927859. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*